Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BENAIM S., DIXON M. F. Jaundice associated with administration of iproniazid; report of two cases. Br Med J. 1958 Nov 1;2(5104):1068–1070. doi: 10.1136/bmj.2.5104.1068. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KAHN M., PEREZ V. Jaundice associated with the administration of iproniazid; report of nine cases. Am J Med. 1958 Dec;25(6):898–916. doi: 10.1016/0002-9343(58)90062-7. [DOI] [PubMed] [Google Scholar]
- PARE C. M., SANDLER M. Acute hepatic necrosis following iproniazid therapy; value of glutamic-oxaloacetic transaminase estimation in early detection. Lancet. 1959 Feb 7;1(7067):282–284. doi: 10.1016/s0140-6736(59)90206-5. [DOI] [PubMed] [Google Scholar]